RBC Capital Reaffirms Their Buy Rating on Ligand Pharma (LGND)
at www.tipranks.com (Fri, 27-Feb 7:06 AM)
Ligand outlines 23% CAGR royalty growth outlook through 2030 as royalty portfolio accelerates
at seekingalpha.com (Thu, 26-Feb 5:48 PM)
Ligand Pharmaceuticals Non-GAAP EPS of $2.02 beats by $0.52, revenue of $59.7M beats by $4.11M
at seekingalpha.com (Thu, 26-Feb 7:10 AM)
Here are the major earnings before the open Thursday
at seekingalpha.com (Wed, 25-Feb 6:00 PM)
Ligand Pharmaceuticals Q4 2025 Earnings Preview
at seekingalpha.com (Wed, 25-Feb 10:12 AM)
Wall Street Analysts Are Bullish on Top Healthcare Picks
at www.tipranks.com (Tue, 24-Feb 11:50 AM)
Analysts Are Bullish on Top Healthcare Stocks: Repligen (RGEN), Myriad Genetics (MYGN)
at www.tipranks.com (Tue, 24-Feb 9:31 AM)
